Please use this identifier to cite or link to this item: https://dora.health.qld.gov.au/qldresearchjspui/handle/1/552
Title: Sebaceous adenoma arising within an ovarian mature cystic teratoma in Muir-Torre syndrome
Authors: Robertson, T.
McGaughran, J.
Smith, J.
Crowe, K.
Issue Date: 2012
Source: December 16, (6), 2012, p. 485-488
Pages: 485-488
Journal: Annals of Diagnostic Pathology
Abstract: This is the first reported case of a sebaceous adenoma arising within an ovarian mature cystic teratoma in a patient with Muir-Torre syndrome. The pathologic findings and a literature review are presented, including the importance and possible benefits of an early diagnosis of Muir-Torre syndrome. It is proposed that the presence of a sebaceous adenoma in an ovarian cystic teratoma may serve as a useful trigger to consider further history and investigations, with the goal of identifying an important genetic cancer predisposition syndrome.
DOI: http://dx.doi.org/10.1016/j.anndiagpath.2011.04.003
Resources: http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed10&AN=2012654162
Keywords: Lynch syndromeMuir-Torre syndrome;Ovarian mature cystic teratoma;Sebaceous adenoma;adult;article;basal cell carcinoma;breast carcinoma;cancer risk;carcinoma;case report;cystectomy;family history;female;gene mutation;genetic counseling;genetic screening;heterozygosity;histopathology;human;human tissue;hysterectomy;immunohistochemistry;intraductal carcinoma/dt [Drug Therapy];intraductal carcinoma/rt [Radiotherapy];intraductal carcinoma/su [Surgery];intraepidermal carcinoma;keratoacanthoma;Muir Torre syndrome;nasolabial fold;ovarian mature cystic teratoma/di [Diagnosis];ovarian mature cystic teratoma/su [Surgery];pelvis radiography;preoperative evaluation;priority journal;salpingooophorectomy;sebaceous gland adenoma/di [Diagnosis];skin biopsy;skin tumor/di [Diagnosis];teratoma/di [Diagnosis];teratoma/su [Surgery];tumor volume;mismatch repair protein PMS2/ec [Endogenous Compound];protein MLH1/ec [Endogenous Compound];protein MSH2/ec [Endogenous Compound];protein MSH6/ec [Endogenous Compound];tamoxifen/dt [Drug Therapy];tamoxifen/po [Oral Drug Administration]
Type: Article
Appears in Sites:Sunshine Coast HHS Publications

Show full item record

Page view(s)

116
checked on Mar 27, 2025

Google ScholarTM

Check

Altmetric


Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.